 Source: CI Photos Shutterstock.com BioAffinity NASDAQ: BIAF stock is rising higher on Wednesday after the cancer diagnostic company announced the publication of its research in PLOS ONE . This was published under the title Sputum analysis by flow cytometry; an effective platform to analyze the lung environment. 